Literature DB >> 20625078

Hypertension awareness and psychological distress.

Mark Hamer1, G David Batty, Emmanuel Stamatakis, Mika Kivimaki.   

Abstract

There is conflicting evidence regarding the association of hypertension with psychological distress, such as anxiety and depressive symptoms. The association may be because of a direct effect of the raised blood pressure, adverse effects of treatment, or the consequences of labeling. In a representative study of 33 105 adults (aged 51.7+/-12.1 years; 45.8% men), we measured levels of psychological distress using the 12-item General Health Questionnaire and collected blood pressure, data on history of hypertension diagnosis, and medication usage. Awareness of hypertension was confirmed through a physician diagnosis or the use of antihypertensive medication, and unaware hypertension was defined by elevated clinic blood pressure (systolic/diastolic > or =140/90 mm Hg) without previous treatment or diagnosis. In comparison with normotensive participants, an elevated risk of distress (General Health Questionnaire score > or =4) was observed in aware hypertensive participants (multivariable adjusted odds ratio: 1.57 [95% CI: 1.41 to 1.74]) but not in unaware hypertensives (odds ratio: 0.91 [95% CI: 0.78 to 1.07]). Antihypertensive medication and comorbidity were also associated with psychological distress, although this did not explain the greater risk of distress in aware hypertensives. We observed a weak curvilinear association between systolic blood pressure and distress, which suggested that distressed participants were more likely to have low or highly elevated blood pressure. These findings suggest that labeling individuals as hypertensive, rather than having elevated blood pressure, per se, may partially explain the greater levels of distress in patients treated for hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625078      PMCID: PMC3319302          DOI: 10.1161/HYPERTENSIONAHA.110.153775

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  19 in total

1.  Blue genes and the monoamine hypothesis of depression.

Authors:  S M Stahl
Journal:  J Clin Psychiatry       Date:  2000-02       Impact factor: 4.384

2.  Association of low blood pressure with anxiety and depression: the Nord-Trøndelag Health Study.

Authors:  Bjørn Hildrum; Arnstein Mykletun; Eystein Stordal; Ingvar Bjelland; Alv A Dahl; Jostein Holmen
Journal:  J Epidemiol Community Health       Date:  2007-01       Impact factor: 3.710

3.  The validity of two versions of the GHQ in the WHO study of mental illness in general health care.

Authors:  D P Goldberg; R Gater; N Sartorius; T B Ustun; M Piccinelli; O Gureje; C Rutter
Journal:  Psychol Med       Date:  1997-01       Impact factor: 7.723

4.  Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension.

Authors:  Carmilla M M Licht; Eco J C de Geus; Adrie Seldenrijk; Hein P J van Hout; Frans G Zitman; Richard van Dyck; Brenda W J H Penninx
Journal:  Hypertension       Date:  2009-02-23       Impact factor: 10.190

5.  Awareness of high blood pressure increases arterial plasma catecholamines, platelet noradrenaline and adrenergic responses to mental stress.

Authors:  M Rostrup; H H Mundal; A Westheim; I Eide
Journal:  J Hypertens       Date:  1991-02       Impact factor: 4.844

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Baseline depressive symptoms are not associated with clinically important levels of incident hypertension during two years of follow-up: the multi-ethnic study of atherosclerosis.

Authors:  Joseph A C Delaney; Bruce E Oddson; Holly Kramer; Steven Shea; Bruce M Psaty; Robyn L McClelland
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

8.  Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons.

Authors:  Suvi T Ruohonen; Eriika Savontaus; Petteri Rinne; Joana Rosmaninho-Salgado; Claudia Cavadas; Heikki Ruskoaho; Markku Koulu; Ullamari Pesonen
Journal:  Neuroendocrinology       Date:  2008-12-20       Impact factor: 4.914

9.  The impact of perceived hypertension status on anxiety and the white coat effect.

Authors:  Tanya M Spruill; Thomas G Pickering; Joseph E Schwartz; Elizabeth Mostofsky; Gbenga Ogedegbe; Lynn Clemow; William Gerin
Journal:  Ann Behav Med       Date:  2007-08

10.  Major depression as a risk factor for high blood pressure: epidemiologic evidence from a national longitudinal study.

Authors:  Scott B Patten; Jeanne V A Williams; Dina H Lavorato; Norman R C Campbell; Michael Eliasziw; Tavis S Campbell
Journal:  Psychosom Med       Date:  2009-02-05       Impact factor: 4.312

View more
  46 in total

1.  Psychological Distress and Hypertension: Results from the National Health Interview Survey for 2004-2013.

Authors:  Nwakile Ojike; James R Sowers; Azizi Seixas; Joseph Ravenell; G Rodriguez-Figueroa; M Awadallah; F Zizi; Girardin Jean-Louis; Olugbenga Ogedegbe; Samy I McFarlane
Journal:  Cardiorenal Med       Date:  2016-02-25       Impact factor: 2.041

2.  Is ignorance bliss? Depression, antidepressants, and the diagnosis of prediabetes and type 2 diabetes.

Authors:  Briana Mezuk; Vicki Johnson-Lawrence; Hedwig Lee; Jane A Rafferty; Cleopatra M Abdou; Ekeoma E Uzogara; James S Jackson
Journal:  Health Psychol       Date:  2013-03       Impact factor: 4.267

3.  Are personality traits associated with white-coat and masked hypertension?

Authors:  Antonio Terracciano; Angelo Scuteri; James Strait; Angelina R Sutin; Osorio Meirelles; Michele Marongiu; Marco Orru; Maria Grazia Pilia; Luigi Ferrucci; Francesco Cucca; David Schlessinger; Edward Lakatta
Journal:  J Hypertens       Date:  2014-10       Impact factor: 4.844

4.  Depressive symptoms associated with physical health problems in midlife women: A longitudinal study.

Authors:  Holly J Jones; Pamela A Minarik; Catherine L Gilliss; Kathryn A Lee
Journal:  J Affect Disord       Date:  2019-12-02       Impact factor: 4.839

5.  Race differences in the physical and psychological impact of hypertension labeling.

Authors:  Tanya M Spruill; Linda M Gerber; Joseph E Schwartz; Thomas G Pickering; Gbenga Ogedegbe
Journal:  Am J Hypertens       Date:  2012-01-19       Impact factor: 2.689

6.  Impact of single-visit American versus European office blood pressure measurement procedure on individual blood pressure classification: a cross-sectional study.

Authors:  Annina S Vischer; Thenral Socrates; Clemens Winterhalder; Jens Eckstein; Michael Mayr; Thilo Burkard
Journal:  Clin Res Cardiol       Date:  2019-02-06       Impact factor: 5.460

7.  Grape powder supplementation prevents oxidative stress-induced anxiety-like behavior, memory impairment, and high blood pressure in rats.

Authors:  Farida Allam; An T Dao; Gaurav Chugh; Ritu Bohat; Faizan Jafri; Gaurav Patki; Christopher Mowrey; Mohammad Asghar; Karim A Alkadhi; Samina Salim
Journal:  J Nutr       Date:  2013-04-17       Impact factor: 4.798

8.  Are there consequences of labeling patients with prehypertension? An experimental study of effects on blood pressure and quality of life.

Authors:  Tanya M Spruill; Seth D Feltheimer; Manjunath Harlapur; Joseph E Schwartz; Gbenga Ogedegbe; Youngjun Park; William Gerin
Journal:  J Psychosom Res       Date:  2013-02-15       Impact factor: 3.006

Review 9.  Anxiety in the "age of hypertension".

Authors:  James Brian Byrd; Robert D Brook
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

10.  Psychological distress as a risk factor for death from cerebrovascular disease.

Authors:  Mark Hamer; Mika Kivimaki; Emmanuel Stamatakis; G David Batty
Journal:  CMAJ       Date:  2012-06-18       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.